制藥網(wǎng)>產(chǎn)品庫(kù)>原料藥中間體、制劑>中間體>醫(yī)藥中間體>>帕拉米韋三水合物

帕拉米韋三水合物

參考價(jià)	￥ 1000
訂貨量	≥1 把

具體成交價(jià)以合同協(xié)議為準(zhǔn)

公司名稱(chēng)泓博智源（開(kāi)原）藥業(yè)有限公司
品牌其他品牌
型號(hào)CAS#1041434-82-5
所在地鐵嶺市
廠(chǎng)商性質(zhì)生產(chǎn)廠(chǎng)家
更新時(shí)間2022/6/16 16:16:35
訪(fǎng)問(wèn)次數(shù)597

產(chǎn)品標(biāo)簽:

Paramivir trihydrate 醫(yī)藥中間體自研銷(xiāo)售

在線(xiàn)詢(xún)價(jià) 收藏產(chǎn)品查看電話(huà) 同類(lèi)產(chǎn)品

聯(lián)系我們時(shí)請(qǐng)說(shuō)明是制藥網(wǎng) 上看到的信息，謝謝!

索取相關(guān)資料

公司介紹主營(yíng)產(chǎn)品

位于遼寧省開(kāi)原市的泓博智源（開(kāi)原）藥業(yè)作為生產(chǎn)基地，占地面積 6 萬(wàn)平方米，擁有符合現(xiàn)行 GMP 標(biāo)準(zhǔn)的廠(chǎng)房、設(shè)備設(shè)施和檢驗(yàn)系統(tǒng)，主要從事國(guó)際前沿的化學(xué)原料藥及中間體的研發(fā)、生產(chǎn)和銷(xiāo)售，現(xiàn)有產(chǎn)品包括替格瑞洛、帕拉米韋、維帕他韋、索菲布韋等，已經(jīng)取得歐盟 COS 證書(shū)和多項(xiàng)國(guó)際認(rèn)證，同時(shí)與 Novartis, Sanofi, Chemo、TEVA、 Dr Reddy, Cipla 等多家國(guó)外企業(yè)長(zhǎng)期合作，具備長(zhǎng)足發(fā)展的巨大潛力。

展開(kāi)顯示更多內(nèi)容

替格瑞洛原料藥等其他原料藥及中間體

產(chǎn)品簡(jiǎn)介在線(xiàn)詢(xún)價(jià)

CAS號(hào)	1041434-82-5	產(chǎn)地	國(guó)產(chǎn)
級(jí)別	藥用級(jí)	證書(shū)	GMP證書(shū)
kg	1

PharmaResources (Kaiyuan) Co., Ltd, the subsidiary of PR., is located in Kaiyuan City, Liaoning Province. PR Kaiyuan), is a GMP certified manufacturer with a pilot plant of 60,000 square meters.

帕拉米韋三水合物產(chǎn)品信息

PharmaResources (Kaiyuan) Co., Ltd, the subsidiary of PR., is located in Kaiyuan City, Liaoning Province. PR Kaiyuan), is a GMP certified manufacturer with a pilot plant of 60,000 square meters. The plant is focused on the R&D, manufacture (including CMO service) and sales of advanced intermediates and APIs that are highly demanded in the global market. PharmaResources (Kaiyuan) has several commercial products including Ticagrelor API and intermediates, Levocarnitine API, Peramivir intermediates, Velpatasvir intermediates, Sofosbuvir intermediates etc., some of which have obtained COS certificate of EU and certificates from other countries. .